Nurx Overview
Latest Deal Type
Series C1
Latest Deal Amount
$13.3M
Nurx General Information
Description
Provider of a medication prescription and delivery platform intended to put women in control of their own health. The company's platform allows users to request for medications and get delivery without the need to visit a doctor, hospital or consult any medical professional, enabling women to have safe and timely access to birth control.
Nurx Timeline
Want to dig into this profile?
We’ll help you find what you need
Learn more
Nurx Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 7. Later Stage VC (Series C1) |
23-Dec-2019 |
$13.3M |
00000 |
00000 |
Completed |
Generating Revenue |
| 6. Debt - General |
05-Nov-2019 |
0000 |
00000 |
|
Completed |
Generating Revenue |
| 5. Later Stage VC (Series C) |
30-May-2019 |
0000 |
000.00 |
00000 |
Completed |
Generating Revenue |
| 4. Early Stage VC (Series B) |
06-Dec-2017 |
000.00 |
000.00 |
00000 |
Completed |
Generating Revenue |
| 3. Early Stage VC (Series A) |
01-Nov-2016 |
00.00 |
00.000 |
000.00 |
Completed |
Generating Revenue |
| 2. Accelerator/Incubator |
22-Mar-2016 |
$120K |
$120K |
00.000 |
Completed |
Startup |
| 1. Angel (individual) |
15-Sep-2015 |
|
|
|
Completed |
Startup |
Nurx Cap Table
To view Nurx‘s complete cap table, request access >>
| Stock |
# of Shares
Authorized |
Par Value |
Dividend Rate (%) |
Original
Issue Price |
Liquidation |
Liquidation
Pref. Multiple |
Conversion Price |
% Owned |
| Series C-1 |
0,000,000 |
00.000000 |
|
00.00 |
00.00 |
00 |
00.00 |
0.000 |
| Series C |
0,000,000 |
00.000000 |
|
00.00 |
00.00 |
00 |
00.00 |
00.000 |
| Series B2 |
000,000 |
00.000000 |
|
00.00 |
00.00 |
00 |
00.00 |
0.000 |
| Series B1 |
0,000,000 |
00.000000 |
|
00.00 |
00.00 |
00 |
00.00 |
00.000 |
| Series A-4 |
000,000 |
00.000000 |
|
00.00 |
00.00 |
00 |
00.00 |
0.000 |
| Series A-3 |
000,000 |
00.000000 |
|
00.00 |
00.00 |
00 |
00.00 |
0.000 |
| Series A-2 |
745,944 |
$0.000010 |
|
$0.37 |
$0.37 |
1x |
$0.37 |
1.82% |
| Series A-1 |
4,081,144 |
$0.000010 |
|
$1.18 |
$1.18 |
1x |
$1.18 |
9.95% |
Nurx Competitors (14)
| Company Name |
Financing Status |
Location |
Employees |
Total Raised |
Last Financing Date/Type |
Last Financing
Amount |
| Medici (Application Software) |
Venture Capital-Backed |
Austin, TX |
00 |
000.00 |
0000000000 |
000.00 |
| 000000000 |
Venture Capital-Backed |
San Francisco, CA |
00 |
00.00 |
00000000000 |
00.00 |
| 000000 000000 |
Venture Capital-Backed |
Sunnyvale, CA |
|
00.000 |
000000000 |
00.000 |
| 000000000000 |
Venture Capital-Backed |
Madison, WI |
0 |
00.000 |
0000000000 0 |
00.000 |
| 00000 |
Venture Capital-Backed |
New York, NY |
000 |
000.00 |
00000000000 |
000.00 |
Nurx Executive Team (10)
| Name |
Title |
Board Seat |
Contact Info |
| Varsha Rao |
Chief Executive Officer & Board Member |
|
|
| Ori Franco |
Chief Financial Officer |
|
|
| Sheena Deol |
Executive Assistant |
|
|
| Edvard Engesaeth MD |
Co-Founder, Innovation Officer & Board Member |
|
|
| Hans Gangeskar |
Co-Founder |
|
|
2 Former Executives